Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population

Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685–1695. 2005. View Article : Google Scholar : PubMed/NCBI

Hansson GK, Libby P, Schonbeck U and Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 91:281–291. 2002. View Article : Google Scholar : PubMed/NCBI

De Boer OJ, Becker AE and van der Wal AC: T lymphocytes in atherogenesis-functional aspects and antigenic repertoire. Cardiovasc Res. 60:78–86. 2003.PubMed/NCBI

Walker LS, Gulbranson-Judge A, Flynn S, Brocker T and Lane PJ: Co-stimulation and selection for T-cell help for germinal centres: The role of CD28 and OX40. Immunol Today. 21:333–337. 2000. View Article : Google Scholar : PubMed/NCBI

Weinberg AD: Ox40: targeted immunotherapy – implications for tempering autoimmunity and enhancing vaccines. Trends Immunol. 23:102–109. 2002.

Ria M, Eriksson P, Boquist S, Ericsson CG, Hamsten A and Lagercrantz J: Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Commun. 339:1001–1006. 2006. View Article : Google Scholar : PubMed/NCBI

Mashimo Y, Suzuki Y, Hatori K, Tabara Y, Miki T, Tokunaga K, Katsuya T, Ogihara T, Yamada M, Takahashi N, Makita Y, Nakayama T, Soma M, Hirawa N, Umemura S, Ohkubo T, Imai Y and Hata A: Association of TNFRSF4 gene polymorphisms with essential hypertension. J Hypertens. 26:902–913. 2008. View Article : Google Scholar : PubMed/NCBI

Wang X, Ria M, Kelmenson PM, Eriksson P, et al: Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet. 37:365–372. 2005. View Article : Google Scholar : PubMed/NCBI

Malarstig A, Eriksson P, Rose L, Diehl KA, Hamsten A, Ridker PM and Zee RY: Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem. 54:833–840. 2008. View Article : Google Scholar : PubMed/NCBI

Van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ and Kuiper J: Interruption of the TNFRSF4/TNFSF4 (OX40/OX40l) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 27:204–210. 2007.PubMed/NCBI

Menashe I, Rosenberg PS and Chen BE: PGA: Power calculator for case-control genetic association analyses. BMC Genet. 9:362008. View Article : Google Scholar : PubMed/NCBI

Hansson GK, Robertson AK and Soderberg-Naucler C: Inflammation and atherosclerosis. Annu Rev Pathol. 1:297–329. 2006. View Article : Google Scholar

Koch W, Hoppmann P, Mueller JC, Schomig A and Kastrati A: Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population. Nat Genet. 40:1386–1388. 2008. View Article : Google Scholar : PubMed/NCBI

Olofsson PS, Soderstrom LA, Jern C, Sirsjo A, Ria M, Sundler E, de Faire U, Wiklund PG, Ohrvik J, Hedin U, Paulsson-Berne G, Hamsten A, Eriksson P and Hansson GK: Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med. 87:337–346. 2009. View Article : Google Scholar : PubMed/NCBI